作者总结了１９６８年１２月至１９８６年１２月腮腺癌１４８例治疗和随访。５年、１０年、１５年生存率分别为６０．１％、４７．１％、４３．５％．其手术范围和面神经是否保留应根据病变大小、临床分期、病理性质而决定。早期治疗、首次治疗的成功、原发灶的彻底手术及术后综合治疗是提高疗效的重要因素。对腮腺癌的疗效评价应区分低度和高度恶性为宜。 The authors summarize the treatment and follow-up of 148 patients with parotid cancer from December 1968 to December 1986. The 5-year, 10-year and 15-year survival rates were 60.1%, 47.1% and 43.5% respectively. The scope of surgery and facial nerve should be retained according to the size of the lesion, clinical stage, the pathological nature of the decision. Early treatment, the success of the first treatment, complete primary surgery and postoperative comprehensive treatment is an important factor in improving efficacy. Evaluation of the efficacy of parotid cancer should distinguish between low and high degree of malignancy is appropriate.